Literature DB >> 29852174

Dual-specificity phosphatase 18 modulates the SUMOylation and aggregation of Ataxin-1.

Joohyun Ryu1, Do Hee Lee2.   

Abstract

We previously reported that SUMOylation promotes the aggregation of ataxin-1 and JNK is involved in the process. Here we show that dual-specificity phosphatase 18 (DUSP18), a member of protein tyrosine phosphatases, exerts the opposite effects on ataxin-1. DUSP18 associated with ataxin-1 and suppressed JNK activated by ataxin-1. Interestingly DUSP18, but not the other DUSPs interacting with ataxin-1, caused the mobility shift of ataxin-1. De-phosphorylation by DUSP18 was initially suspected as a cause for such an effect; however, the phosphorylation of ataxin-1 was unchanged. Instead DUSP18 inhibited SUMOylation and reduced ataxin-1 aggregation. The catalytic mutant of DUSP18 failed to reduce the SUMOylation and aggregation of ataxin-1 indicating that the phosphatase activity is indispensable for the effects. Moreover, DUSP18 disrupted the co-localization of ataxin-1 with the PML component Sp100. These results together implicate that JNK and DUSP18 reciprocally modulate the SUMOylation, which plays a regulatory role in the aggregation of ataxin-1.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ataxin-1; Dual-specificity phosphatase 18; JNK; Polyglutamine; SUMO-1

Mesh:

Substances:

Year:  2018        PMID: 29852174     DOI: 10.1016/j.bbrc.2018.05.178

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Pathogenic mechanisms underlying spinocerebellar ataxia type 1.

Authors:  Leon Tejwani; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

2.  Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1.

Authors:  Jiu-Ming Chen; Shi-Kai Chen; Pei-Pei Jin; Shun-Chang Sun
Journal:  Hum Genomics       Date:  2022-07-29       Impact factor: 6.481

3.  Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways.

Authors:  Denisse A Gutierrez; Lisett Contreras; Paulina J Villanueva; Edgar A Borrego; Karla Morán-Santibañez; Jessica D Hess; Rebecca DeJesus; Manuel Larragoity; Ana P Betancourt; Jonathon E Mohl; Elisa Robles-Escajeda; Khodeza Begum; Sourav Roy; Robert A Kirken; Armando Varela-Ramirez; Renato J Aguilera
Journal:  Cells       Date:  2022-01-12       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.